Skip to content
value.today

CV Sciences, Inc. vs TherapeuticsMD, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • TherapeuticsMD, Inc. is the larger company by market value: $23 M against $20 M for CV Sciences, Inc., 1.1 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 14, 2026 for TherapeuticsMD, Inc.). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
  • CV Sciences, Inc. had more revenue: $14 M against $3 M for TherapeuticsMD, Inc., both in the year to December 2025.
  • Both made a net loss: $1 M for CV Sciences, Inc. and $1 M for TherapeuticsMD, Inc.
  • CV Sciences, Inc. keeps more of each dollar of sales: a net margin of -7.0% against -18.9% for TherapeuticsMD, Inc.
  • TherapeuticsMD, Inc.'s revenue grew faster in its latest fiscal year: +71.6% against -12.2% for CV Sciences, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

02550751002020202120222023202420252026CV Sciences, Inc. 19TherapeuticsMD, Inc. 4

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025CV Sciences, Inc. $0BTherapeuticsMD, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCV Sciences, Inc.
CVSI
TherapeuticsMD, Inc.
TXMD · #23,958 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded2010—
Size
Market cap$20 M*$23 M
Revenue$14 M$3 M
Net income$-1 M$-1 M▲ best
Employees44—
Valuation
Price to sales—6.9×
Price to book—0.8×
Profitability
Gross margin49.0%—
Operating margin-3.4%▲ best-145.4%
Net margin-7.0%▲ best-18.9%
Return on equity-58.7%-2.1%▲ best
Growth
Revenue growth-12.2%71.6%▲ best
Revenue growth, 3 years a year-5.2%—
Financial strength
Debt to equity1.1×—
Interest cover—-439.0×
Cash
Free cash flow margin-3.8%—
Strength scores
Piotroski F-score6 of 9—
Altman Z-score zone—distress
Data as ofMarket cap Jan 2022; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, CV Sciences, Inc. or TherapeuticsMD, Inc.?

TherapeuticsMD, Inc. is the larger company by market value: $23 M against $20 M for CV Sciences, Inc., 1.1 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 14, 2026 for TherapeuticsMD, Inc.). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, CV Sciences, Inc. or TherapeuticsMD, Inc.?

CV Sciences, Inc. had more revenue: $14 M against $3 M for TherapeuticsMD, Inc., both in the year to December 2025. Both made a net loss: $1 M for CV Sciences, Inc. and $1 M for TherapeuticsMD, Inc.

Which is more profitable, CV Sciences, Inc. or TherapeuticsMD, Inc.?

CV Sciences, Inc. keeps more of each dollar of sales: a net margin of -7.0% against -18.9% for TherapeuticsMD, Inc.

Which is growing faster, CV Sciences, Inc. or TherapeuticsMD, Inc.?

TherapeuticsMD, Inc.'s revenue grew faster in its latest fiscal year: +71.6% against -12.2% for CV Sciences, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.